Other studies have shown increased CSF YKL-40 levels in Alzheimer’s disease patients compared with Parkinson’s disease dementia and dementia with Lewy bodies [199], dementia and prodementia with Lewy bodies [53,200], and vascular dementia [53]. This evidence concerns the gene CHI3L1 and vascular dementia.